Given that interactions between nervous system and cancer cells can promote cancer progression, we hypothesized that patients with co-high expression of notable interactions (APOD_VDAC1, APOD_PDZK1IP1, and CLDN4_APOD) would have poor prognosis. Here, APOD is linked to cancer.